Recovery of dopamine neuronal transporter but lack of change of its mRNA in substantia nigra after inactivation by a new irreversible inhibitor characterized in vitro and ex vivo i...

Por Do Régo, Jean-Claude, Syringas, Maria, Leblond, Bertrand, Costentin, Jean, Bonnet, Jean-Jacques
Publicado em 1999

Rap1-Rac1 Circuits Potentiate Platelet Activation

Por Stefanini, Lucia, Boulaftali, Yacine, Ouellette, Timothy D., Holinstat, Michael, Désiré, Laurent, Leblond, Bertrand, Andre, Patrick, Conley, Pamela B., Bergmeier, Wolfgang
Publicado em 2011

Therapeutic sensitivity to Rac GTPase inhibition requires consequential suppression of mTORC1, AKT, and MEK signaling in breast cancer

Por Hampsch, Riley A., Shee, Kevin, Bates, Darcy, Lewis, Lionel D., Désiré, Laurent, Leblond, Bertrand, Demidenko, Eugene, Stefan, Kurtis, Huang, Yina H., Miller, Todd W.
Publicado no Oncotarget (2017)

DYRK1A controls the transition from proliferation to quiescence during lymphoid development by destabilizing Cyclin D3

Por Thompson, Benjamin J., Bhansali, Rahul, Diebold, Lauren, Cook, Daniel E., Stolzenburg, Lindsay, Casagrande, Anne-Sophie, Besson, Thierry, Leblond, Bertrand, Désiré, Laurent, Malinge, Sébastien, Crispino, John D.
Publicado no J Exp Med (2015)